ETLT - News:
Eternal Technologies Group`s ``Breeding Base of Fine American
Dairy Cattle`` Completed First Step with Success
November 07, 2005 09:00:13 (ET)
HOUSTON, Nov 07, 2005 (BUSINESS WIRE) -- Eternal Technologies Group, Inc. (ETLT, Trade) a leader in the cattle embryo-transfer industry has successfully completed phase one of building a breeding base of fine American dairy cattle in China. During phase one, 2,000 yellow cows were purchased and transferred to farming facilities where they will be used as host animals for dairy-cow embryo transfers. The purchase of these 2,000 head of cattle marks a major milestone in the strategic growth of the company and is one of the initial investments in a 37 million US dollars investment program. To date, all of the cattle have been registered, documented, and branded. The purchased cattle were culled from a pool of approximately 6,000 candidates and were chosen for their physical condition, adaptability and history of successful gestation and reproduction.
By using the comparatively inexpensive domestic yellow cow as surrogate mothers to produce thoroughbred dairy cattle on a mass scale, the company will be able to decrease its production cost, and reconfirm its leading position in the embryo transplantation industry. The cost of a yellow cow is approximately one quarter of that of a dairy cow, and each surrogate yellow cow is capable of undergoing multiple transplantations. While the time required for the reproduction cycle of breeding cattle is fixed, the method used by ETLT to introduce dairy cattle into mainland China is both a practical and efficient method of accelerating the proliferation of fine dairy cattle. This will be a key factor in facilitating ETLT's growth. ETLT is now scheduling the technical resources for the transfer cycle.
ETLT estimates that the surrogate cattle will deliver pedigree Holstein heifer calves in September 2006. After a three-month period, the calves will be distributed to dairy producers across the country to ease the shortage of quality dairy cattle in China.
As a complementary project ETLT is establishing an "embryo production laboratory for the production of fine dairy cows." This is another integral part of the company's strategic plan as well as the establishment of operations in the U.S.
About Eternal Technologies
Eternal is a major agricultural genetics and biopharmaceutical R&D firm operating in China with the support of the Chinese Government. Eternal's animal breeding division has a strong asset base, cash position and net income. Eternal has become one of China's leading institutions for biopharmaceutical and biotech research, pure breed cultivation and breed stock production. The Company has secured a key market niche by commercializing gene engineering technologies and providing superior breeding stock, allowing China's citizens the ability to improve their living standards. With the world's largest population, a double-digit national growth rate and entry into the WTO, Eternal Technologies has a playing field set for tremendous opportunity. As a prominent player in the agricultural genetics industry, cash in the bank and an untapped market, Eternal has the potential to become a major player in China's national growth.
